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ABSTRACT
Background: Pregnancy losses (PLs) are usually a source of pain and psychological stress to the expectant couples. The 
association between ABO blood groups and some thrombogenic markers with PL among Nigerian women is mostly unknown. 
Aim: This study investigates the association between ABO blood group, deficiencies of protein C (PC), and protein S (PS) 
and PL.
Patients and Methods: A cross‑sectional study involving 170 pregnant women grouped into two, those with or without a 
history of clinically‑ or ultrasonographically recognizable PL. ABO blood groups using the tile method, plasma concentrations 
of free protein S (fPS) antigen, protein C antigen (PCAg) by the enzyme‑linked immunosorbent assay‑based method, and 
PC activity (PCAc) by PROTAC method was determined.
Results: There was no difference in mean values between the two groups for PCAg, PCAc, FPS, and blood group (P > 0.05). 
The chances of PL were; non‑O blood group (AOR 1.29; 95% CI 0.65‑‑2.54), deficient PCAg (AOR 1.75; 95% CI 0.87‑‑3.54), 
and deficient PCAc (AOR 1.05;95%CI 0.25‑‑4.13). There was a very poor correlation of miscarriage with FPS (rho 0.04), 
PCAg (rho 0.09), and PCAc (rho = 0.05).
Conclusion: There was no significant association between PLs and ABO blood group phenotypes, PCAg, PCAc, fPS.
Key words: Free protein S; Nigerian women; pregnancy loss; protein C antigen; thrombogenic markers.
Introduction
Unplanned miscarriages or pregnancy losses (PLs) are usually 
a source of pain and psychological stress to the expectant 
couple. It becomes recurrent when the woman experiences 
three or more consecutive PLs[1] with the incidence of about 
5%, which varies with the time and cause of PL.[2] The rate 
is higher among blacks who are known to have over the 
three-fold increased risk of miscarriages and fetal deaths than 
their white counterparts.[3] There are different identifiable 
possible causes that have been identified including genetic 
abnormalities, endocrine derangements, anatomical defects, 
hematological disorders, and infections.[4]
Controversies exist as to the importance of thrombophilia 
in PL.[5] Thrombophilia may account for up to 40--55% 
of recurrent PL.[6] However, Parand et al. reported that 
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PL is mostly not associated with all thrombophilia.[6] 
Pregnancy being a prothrombotic state, deficiency of the 
natural anticoagulants, protein S (PS), and protein C (PC), 
heightens the likelihood of thrombotic events in pregnancy. 
Deficiencies of PC, PS, and presence of non-O blood 
group are possible risk factors for adverse pregnancy 
outcomes including PL and thromboembolism.[6,7] For PL, 
the pathogenetic mechanism is presumed to be because of 
thrombosis in the decidual vessels or sites of implantation 
with resultant infarction and placental insufficiency which 
impair blood flow to the fetus, thereby causing intrauterine 
growth restriction or death.[3]
Indeed the contributions of non-O blood group, PC, and PS to 
poor pregnancy outcome have been previously described.[8] 
Most of these studies were on Caucasians or non-blacks with 
a paucity of data among Nigerian women who are thought to 
have a different prevalence of thrombophilia.[5,6] Furthermore, 
recurrent PL may be the first presentation of a hematological 
problem,[2] thus the need for complete hematological workup 
is critical to identify possible risk factors in such patients 
who present with unknown etiology. This study investigates 
the association of ABO blood group, deficiencies of PC and 
PS with PLs.
Patients and Methods
The study center was the Obstetrics and Gynecology 
unit of the University of Port Harcourt Teaching Hospital. 
The choice of study subjects was by probability sampling 
method. A systematic sampling method, the second of every 
three-clinic attendee was chosen. A total of 170 healthy 
consenting pregnant women were interviewed with the 
aid of a pre-tested, pre-validated structured questionnaire. 
Sociodemographics, anthropometric data, medical data, 
history of loss of clinically-/ultrasonographically recognized 
pregnancies, gynecologic and parities were obtained.
Women with evidence of liver, renal, or sickle cell diseases 
or thrombotic disorder (acute phase) and receiving vitamin 
K and anticoagulant/antifibrinolytic therapies were excluded 
from the study. The institutional ethical committee approved 
this study, and informed consent was obtained from the 
participants. There were two groups of study subjects: 
group A comprising of 60 women with a history of one or 
more previous PLs, group B which included 110 women 
who had no history of PL at the time of recruitment. 
Participants were included in group A if there was a positive 
pregnancy test confirmation of index pregnancy as well as 
the ultrasonographical recognizable pregnancy of 24 weeks 
or less.[9] Women who were unsure about the ultrasound 
diagnosis were excluded from the study.
Blood samples were collected from the participants for ABO 
blood group phenotyping and determination of PC and 
PS levels. ABO blood group was determined using the tile 
method as previously described.[10] PC and FPS antigen levels 
were determined using the enzyme-linked immunosorbent 
assay (ELISA)-based methods outlined in Technozym and 
Zymutest Hyphen BioMed test kits, respectively,[11,12] 
whereas the activity level of PC was evaluated with 
Technochrom using the PROTAC method by Technoclone.[10] 
For this study, the ABO blood types were grouped as “O blood 
group” and “non-O (A, B, AB) blood groups,” the subject was 
regarded as being deficient if PCAg, PCAc, and FPS levels 
were <70%, <70%, and <20%, respectively.
Data were analyzed using IBM Statistical Package for Social 
Sciences version 21 (Chicago, Illinois, USA). Findings were 
presented in tables using frequencies and proportion for 
categorical variables as well as a mean and standard deviation 
for quantitative variables. Associations of PL with blood 
group, PCAg, PCAc, and FPS levels were determined using 
Chi-square test. Spearman rho correlation coefficient was 
equally used for the relationship between variables including 
age, parity, PCAg, PCAc, and FPS levels. Level of significance 
was at P ≤ 0.05.
Results
Sociodemographic characteristic
Of the 170 pregnant women recruited for the study, 110 (65%) 
of Group A had no previous miscarriages, whereas 60 (35%) 
reported the previous history of one or more PL. The mean 
age and SD of women in group A and B were 30.2 (4.4) and 
30.7 (5.1), respectively. Most in group A and B were of the 
O blood group, 69 (63%) and 41 (68%), respectively [Table 1].
Comparison of mean levels of PCAg, PCAc, and fPS and 
other variables between Group A and B
The mean and SD levels of PCAg, FPS, and PCAc in group A 
were 80.1 (25.2), 51.5 (16.6), and 112.4 (29.1), whereas those 
of group B were 77.8 (28.8), 52.1 (16.6), and 112.1 (30.2), 
Table 1: Characteristics of participants
Variables A (Miscarriage) 
n=60





Mean Std dev Mean Std dev
Age 30.2 4.4 30.7 5.1 0.64 0.520
Parity 1.2 1.4 1.4 1.5 0.74 0.460
Protein_C_antigen 80.1 25.2 77.8 28.8 0.51 0.612
Protein_C_activity 112.4 29.1 112.1 30.2 0.06 0.955
Free_protein_S 51.5 16.6 52.1 16.6 0.19 0.848
Blood group Number Percent Number Percent χ2 P
Non‑O 19 31.7 41 37.3 0.53 0.465
O 41 68.3 69 62.7
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respectively. It was observed that 20 (29.4%) and 3 (27.3%) 
of participants with history of PL were deficient in PCAg and 
PCAc, respectively. Comparison of these mean levels of these 
variables between the group using t-test was nonsignificant 
as P > 0.05; for age (P = 0.520), parity (P = 0.460), 
PCAg (P = 0.612), PCAc (P = 0.955), fPS (P = 0.848), and 
blood group (P = 0.465) [Table 1].
The relationship between levels of PCAg, PCAc, fPS, 
and PL
Table 2 shows that there were no statistically significant 
associations of PL with blood group (2 = 0.53, P = 0.465), 
fPS (FT, P = 0.123), PCAg (2 = 1.72, P = 0.190), and 
PCAc (0.33, P = 0.749). It showed that non-O blood group 
was 1.3 times more likely to experience PL than those of 
blood group O (AOR 1.29; 95% CI 0.65--2.54) although this 
was not statistically significant. Those women with deficient 
PCAg were 1.8 times more likely to experience PL than those 
of normal PCAg (AOR 1.75; 95% CI 0.87--3.54), whereas those 
with deficient PCAc were about 1.1 times nonstatistically 
significant likely to have PL than those of normal PCAc (AOR 
1.05; 95% CI 0.25--4.13).
There was a nonsignificant poor correlation of PL with 
age (rho = 0.08), Parity (rho = 0.05), PS (rho = 0.04), PC 
antigen (rho = 0.09), and PC activity (rho = 0.05) [Table 3].
Discussion
PL is not uncommon, occurring in upto 5% of women[2] and 
more in blacks.[3] Its cause is unknown in 50% of cases.[13]
In this study, the mean levels of PCAg, PCAc, and FPS 
were all above reference value and showed no significant 
difference between both groups. In our study, there was no 
significant association between non-O blood group women 
in group A and PL. Possible explanations by the findings in 
work done by Spiezia et al.[14] observed a three-fold increase 
in the risk of a thrombotic event in non-O blood group 
individuals with pre-existing thrombophilia, suggesting 
an additive effect. This study recorded lower incidences of 
deficiency of natural anticoagulants unlike their research, 
this could have weakened the strength of the association 
in our study.
Deficiencies of these proteins worsen the prothrombotic 
state of pregnancy and increase the likelihood of adverse 
pregnancy outcomes like PL. However, this study observed 
no significant statistical difference between deficiencies of 
PS and PC among women with or without a history of PL 
and as such there was no significant association between 
deficiencies of PCAg, PCAc, and FPS with PL. This finding 
is in keeping with the work done in Colombia by Cardona 
et al.[15] on Colombian women where he concluded that the 
low prevalence of thrombophilia in non-Caucasian population 
could be a cause.
On the contrary, Mekaj et al.[16] reported that deficiency of 
PC and PS are associated with first trimester PL even though 
thrombophilia is thought to be more contributory to second 
trimester PL. It has also been documented that PC and PS 
deficiency had a significant association with second trimester 
PL. This finding is also consistent with the meta-analysis 
of 31 retrospective study,[17] which had shown that the 
relationship of thrombophilia with late PL is stronger than 
early PL. Participants with PL were grouped in our study, 
irrespective of the trimester the PL occurred; moreover, they 
might have contributed to the reported differences knowing 
that 75% of first-trimester PLs are because of chromosomal 
abnormalities.[18]








No Yes χ2 P AOR 95% CI AOR
Blood group
Non‑O 41 (68.3) 19 (31.7) 0.53 0.465 1.29 0.65‑2.54
O 69 (62.7) 41 (37.3) 1
Protein S
Deficit 0 (0.0) 2 (100.0) FT 0.123 NA
Normal 110 (65.5) 41 (34.5)
Protein C Antigen
Deficit 48 (70.6) 20 (29.4) 1.72 0.190 1.75 0.87‑3.54
Normal 62 (60.8) 40 (39.2) 1
Protein C Activity
Deficit 8 (72.7) 3 (27.3) 0.33 0.749 1.05 0.25‑4.13
Normal 102 (64.2) 57 (35.8) 1
Bivariate analysis, Chi square test, Multivariate analysis, Binary logistic 
regression, AOR, Adjusted Odd Ratio, CI, Confidence Interval, FT, Fischer’s Test, 
NA, Not applicable
Table 3: Relationship of Miscarriage with Thrombogenic 
Markers and other variables





Miscarriage 170 0.8 1.1 −0.08 0.306
Age 170 30.5 4.8
Miscarriage 170 0.8 1.1 0.05 0.518
Parity 170 1.3 1.1
Miscarriage 170 0.8 1.1 0.04 0.627
Protein S 170 51.9 16.3
Miscarriage 170 0.8 1.1 0.09 0.244
Protein C Antigen 170 78.6 27.5
Miscarriage 170 0.8 1.1 0.05 0.491
Protein C Activity 170 112.2 29.7
*rho, Spearman correlation coefficient
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Our study showed there was no significant association 
between women with a history of PL and deficient in 
PCAg and PCAc, suggesting that low-antigen levels do not 
prevent generation of enough activity to carry out required 
anticoagulation function during pregnancy. This may be 
buttressed by the fact that the mean level of PCAc was 
1.4 times higher than the PCAg mean levels in this study.
Deficiency of PS is reported to be the most prevalent 
thrombophilia among the blacks in the United States[19] and 
accounting more for PL among the study group. Irrespective 
of this, the only two subjects that were PS-deficient in this 
study were in the PL group. PS deficiency did not show 
significant association with PL across both groups. It is 
worthy to note that the study excluded individuals with 
conditions that could cause PS deficiency, for example, liver, 
renal, or sickle cell diseases, suggesting that there were some 
unknown factors which may have contributed to the higher 
prevalence of PS deficiency in the former study. Racial and 
geographical constructs could explain these differences.
There was a positive but weak correlation of PL with maternal 
age, PCAg, PCAc, and FPS in this study. Interestingly, the study 
showed PL was more common in older women. The rate of 
PL increases steadily so that by the age of 45 years, there is 
about one-in-two times the risk of PL.[20]
Conclusion
There is no significant association between PL and non-O 
blood group, deficiencies in PS and PC; hence, routine 
thrombophilia screening may not be recommended for all 
women presenting with PL. Other possible options should 
be explored to ascertain the etiology.
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